Literature DB >> 36053437

Hydrogen Sulfide Attenuates High-Fat Diet-Induced Obesity: Involvement of mTOR/IKK/NF-κB Signaling Pathway.

Maofang Zhao1, Yuan Cheng1, Xiaoxuan Wang1, Xiaoying Cui2,3, Xiaojing Cheng1, Qian Fu1, Yilin Song1, Peiquan Yu1, Yi Liu4,5,6, Yinghua Yu7,8.   

Abstract

Obesity has become a public health epidemic worldwide and is associated with many diseases with high mortality including hypertension, diabetes, and heart disease. High-fat diet (HFD)-induced energy imbalance is one of the primary causes of obesity, but the underlying mechanisms are not fully elucidated. Our study showed that HFD reduced the level of hydrogen sulfide (H2S) and its catalytic enzyme cystathionine β-synthase (CBS) in mouse hypothalamus and plasma. We found that HFD activated mTOR, IKK/NF-κB, the main pathway regulating inflammation. Activation of inflammatory pathway promoted the production of pro-inflammatory cytokines including IL-6, IL-1β, and TNF-α, which caused cell damage and loss in the hypothalamus. The disturbance of the hypothalamic neuron circuits resulted in body weight gain in HFD-induced mice. Importantly, we also showed that restoration of H2S level with NaHS or activation of CBS with SAMe attenuated HFD-induced activation of mTOR, IKK/NF-κB signaling, which reduced the inflammation and the neuronal cell loss in the hypothalamus, and also inhibited body weight gain in mice. The same effects were obtained by inhibiting mTOR or NF-κB, which suggested that mTOR and NF-κB were the critical molecular factors involved in hypothalamic inflammation. Taken together, this study identified that HFD-induced hypothalamus inflammation plays a critical role in the development of obesity. Moreover, the inhibition of hypothalamic inflammation by regaining H2S level could be a potential therapeutic to prevent the development of obesity.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Hydrogen sulfide; Hypothalamic inflammation; NF-κB; Obesity; mTOR

Mesh:

Substances:

Year:  2022        PMID: 36053437     DOI: 10.1007/s12035-022-03004-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  48 in total

1.  Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus.

Authors:  Cláudio T De Souza; Eliana P Araujo; Silvana Bordin; Rika Ashimine; Ricardo L Zollner; Antonio C Boschero; Mário J A Saad; Lício A Velloso
Journal:  Endocrinology       Date:  2005-07-07       Impact factor: 4.736

Review 2.  Multiple hypothalamic circuits sense and regulate glucose levels.

Authors:  Mahesh Karnani; Denis Burdakov
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

3.  Microglial Inflammatory Signaling Orchestrates the Hypothalamic Immune Response to Dietary Excess and Mediates Obesity Susceptibility.

Authors:  Martin Valdearcos; John D Douglass; Megan M Robblee; Mauricio D Dorfman; Daniel R Stifler; Mariko L Bennett; Irene Gerritse; Rachael Fasnacht; Ben A Barres; Joshua P Thaler; Suneil K Koliwad
Journal:  Cell Metab       Date:  2018-06-05       Impact factor: 27.287

Review 4.  Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation.

Authors:  K C G de Git; R A H Adan
Journal:  Obes Rev       Date:  2015-01-14       Impact factor: 9.213

Review 5.  Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications.

Authors:  Mark O Goodarzi
Journal:  Lancet Diabetes Endocrinol       Date:  2017-09-14       Impact factor: 32.069

6.  Complications of obesity.

Authors:  G A Bray
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

Review 7.  [Hypothalamic dysfunction in obesity].

Authors:  Simone van de Sande-Lee; Licio A Velloso
Journal:  Arq Bras Endocrinol Metabol       Date:  2012-08

Review 8.  Central nervous system control of food intake and body weight.

Authors:  G J Morton; D E Cummings; D G Baskin; G S Barsh; M W Schwartz
Journal:  Nature       Date:  2006-09-21       Impact factor: 49.962

Review 9.  Treatment of Obesity in Mitigating Metabolic Risk.

Authors:  Sean P Heffron; Johnathon S Parham; Jay Pendse; José O Alemán
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

10.  Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.

Authors:  Zu-Guo Zheng; Si-Tong Zhu; Hui-Min Cheng; Xin Zhang; Gang Cheng; Pyone Myat Thu; Supeng Perry Wang; Hui-Jun Li; Ming Ding; Lei Qiang; Xiao-Wei Chen; Qing Zhong; Ping Li; Xiaojun Xu
Journal:  Autophagy       Date:  2020-05-20       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.